Catalyst Wire Dossier Catalyst Wire Dossier

Suprachoroidal Triamcinolone Acetonide via Microneedle

triamcinolone acetonide · Clearside Biomedical, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Suprachoroidal Triamcinolone Acetonide via Microneedle, covering 2021-02-21 to 2021-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis [Phase 1, Phase 2]

See pricing